ABCC2 and metabolic dysfunction-associated steatohepatitis: Oatp1b2 protein expression decreased to 51% of control in the WT-MCD group, to 33% of control in the Mrp2–/–-NASH group, and was not detected in the Slco1a/1b cluster knockout animals (Fig. 5A and B, middle left panels).